Delivering Localized Trial Access. 

EmVenio Research delivers localized trial access to diverse and underserved communities.

Request Information

We empower patients and embrace communities on their terms. Our research solutions cultivate a sustainable local ecosystem that benefits all stakeholders. Removing barriers and unlocking doors to innovation reduces risk and time associated with clinical research, while improving ROI.

EmVenio Research, now a PCM Trials company, is the largest independent DCT site network and the most experienced provider of local clinical trial access globally. Combined market leadership in mobile visits and Community Research Sites allows us to significantly improve participants’ overall experience in clinical trials.

Global Network.
Mobile Solutions.
Local Access.

45+ Community Research Sites Activated

190+ EmVenio Mobile Clinicians Deployed

It all starts local.

N

Local Communities

N

Local Clinical Trial Access

N

Local Staff

N

Local to YOU

Empowering Peformance

%

Of EmVenio’s trial participants from minority populations, compared to a less than 20% industry average.

%

Retention rate for EmVenio trial participants, compared to a 70% industry average.

%

Of 2,500 patients in a recent study were from underserved populations.